12:15 PM EST - TSO(3) Inc. : announced that the company and 3MTM Infection Prevention Division have amended their December 2009 Global Agreement to include a second product, which is currently in development and destined for use in the operating room. In addition, the companies have agreed to explore the industrial and scientific markets to determine commercial opportunities for the current product (3MTM Optreoz 125-Z). TSO(3) Inc.
shares T.TOS are trading up $0.14 at $1.84.
